TH
THC Therapeutics, Inc.
THCT · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $19.4K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 20.42%
ROA 2,979.49%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.00x
Int. coverage -6.21x
Debt/Equity N/A
Stability
42 /100
Moderate Beta 7.53x
EPS volatility 17.11%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o THCT
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Scott A. Cox
Employees
1
Headquarters
Jacksboro